[4/1/2020] FDA reminds patients not to use any drugs manufactured by Herbal Doctor Remedies, Monterey Park, California, because these drugs were not manufactured under good manufacturing […]

Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) Weight increased The “Adverse Reactions” section of the labeling was updated in February 2024 to include weight increased.  Biktarvy labeling […]

en Español [10/11/2019] FDA advises consumers not to use Rompe Pecho EX and Rompe Pecho CF cough syrups distributed by Efficient Laboratories, Inc., Miami, Florida, due to […]

[6/1/2020] FDA is alerting patients, caregivers and health care professionals to immediately inspect certain lots of Amneal and Impax epinephrine auto-injector 0.3 mg to ensure the yellow […]

Update [8/19/2020] FDA is alerting consumers and health care professionals to Maison Terre’s voluntary recall of all lots of its organic goldenseal root powder. The recalled […]

[9/08/2020] FDA is alerting health care professionals, oncology clinical investigators, and patients that a clinical trial studying the use of atezolizumab (Tecentriq) and paclitaxel in patients […]

[9/21/2020] The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent […]

[2/10/2025] FDA continues to receive reports of tranexamic acid injection being erroneously administered intrathecally instead of the intended intrathecal (spinal) anesthetic (e.g., bupivacaine injection) for neuraxial […]

[4/21/22] FDA worked with drug application holders to remove instructions for preparation of vinca alkaloids by syringe and to recommend preparation in intravenous infusion bags only. […]